Recent Publications

  1. Li M, Li A, Huang H, Munson J, Obadan A, Fuller DH, Waldorf KMA. Impact of progesterone on innate immunity and cell death after influenza A virus H1N1 2009 infection of lung and placental cells in vitro. Front Virol. 2022;2. doi: 10.3389/fviro.2022.953208. Epub 2022 Sep 23. PubMed PMID: 36713466; PubMed Central PMCID: PMC9879262.
  2. Hawman DW, Meade-White K, Clancy C, Archer J, Hinkley T, Leventhal SS, Rao D, Stamper A, Lewis M, Rosenke R, Krieger K, Randall S, Khandhar AP, Hao L, Hsiang TY, Greninger AL, Gale M Jr, Berglund P, Fuller DH, Rosenke K, Feldmann H, Erasmus JH. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine. EBioMedicine. 2022 Sep;83:104196. doi: 10.1016/j.ebiom.2022.104196. Epub 2022 Aug 4. PubMed PMID: 35932641; PubMed Central PMCID: PMC9349033.
  3. Walls AC, VanBlargan LA, Wu K, Choi A, Navarro MJ, Lee D, Avena L, Berrueta DM, Pham MN, Elbashir S, Kraft JC, Miranda MC, Kepl E, Johnson M, Blackstone A, Sprouse K, Fiala B, O’Connor MA, Brunette N, Arunachalam PS, Shirreff L, Rogers K, Carter L, Fuller DH, Villinger F, Pulendran B, Diamond MS, Edwards DK, King NP, Veesler D. Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice. Cell Rep. 2022 Aug 30;40(9):111299. doi: 10.1016/j.celrep.2022.111299. Epub 2022 Aug 15. PubMed PMID: 35988541; PubMed Central PMCID: PMC9376299.
  4. O Connor MA, Hawman DW, Meade-White K, Leventhal S, Song W, Randall S, Archer J, Lewis TB, Brown B, Iwayama N, Ahrens C, Garrison W, Wangari S, Guerriero KA, Hanley P, Lovaglio J, Saturday G, Edlefsen PT, Khandhar A, Feldmann H, Fuller DH, Erasmus JH. A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned. bioRxiv. 2022 Aug 9;. doi: 10.1101/2022.08.08.503239. PubMed PMID: 35982677; PubMed Central PMCID: PMC9387133.
  5. Tortorici MA, Walls AC, Joshi A, Park YJ, Eguia RT, Miranda MC, Kepl E, Dosey A, Stevens-Ayers T, Boeckh MJ, Telenti A, Lanzavecchia A, King NP, Corti D, Bloom JD, Veesler D. Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein. Cell. 2022 Jun 23;185(13):2279-2291.e17. doi: 10.1016/j.cell.2022.05.019. Epub 2022 May 27. PubMed PMID: 35700730; PubMed Central PMCID: PMC9135795.
  6. Hunt AC, Case JB, Park YJ, Cao L, Wu K, Walls AC, Liu Z, Bowen JE, Yeh HW, Saini S, Helms L, Zhao YT, Hsiang TY, Starr TN, Goreshnik I, Kozodoy L, Carter L, Ravichandran R, Green LB, Matochko WL, Thomson CA, Vögeli B, Krüger A, VanBlargan LA, Chen RE, Ying B, Bailey AL, Kafai NM, Boyken SE, Ljubetič A, Edman N, Ueda G, Chow CM, Johnson M, Addetia A, Navarro MJ, Panpradist N, Gale M Jr, Freedman BS, Bloom JD, Ruohola-Baker H, Whelan SPJ, Stewart L, Diamond MS, Veesler D, Jewett MC, Baker D. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice. Sci Transl Med. 2022 May 25;14(646):eabn1252. doi: 10.1126/scitranslmed.abn1252. Epub 2022 May 25. PubMed PMID: 35412328; PubMed Central PMCID: PMC9258422.
  7. Fuller DH, O’Connor MA. Letter to the Editor: Prior Infection with Coccidioidomycosis in Nonhuman Primates and Impact on Simian Immunodeficiency Virus Disease and Vaccine Immunogenicity. AIDS Res Hum Retroviruses. 2022 May;38(5):347-349. doi: 10.1089/AID.2021.0236. Epub 2022 Mar 22. PubMed PMID: 35172614; PubMed Central PMCID: PMC9131037.
  8. Ulrich-Lewis JT, Draves KE, Roe K, O’Connor MA, Clark EA, Fuller DH. STING Is Required in Conventional Dendritic Cells for DNA Vaccine Induction of Type I T Helper Cell- Dependent Antibody Responses. Front Immunol. 2022;13:861710. doi: 10.3389/fimmu.2022.861710. eCollection 2022. PubMed PMID: 35529875; PubMed Central PMCID: PMC9072870.
  9. Willcox AC, Sung K, Garrett ME, Galloway JG, Erasmus JH, Logue JK, Hawman DW, Chu HY, Hasenkrug KJ, Fuller DH, Matsen Iv FA, Overbaugh J. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques. PLoS Pathog. 2022 Apr;18(4):e1010155. doi: 10.1371/journal.ppat.1010155. eCollection 2022 Apr. PubMed PMID: 35404959; PubMed Central PMCID: PMC9022802.
  10. Wang H, Li C, Obadan AO, Frizzell H, Hsiang TY, Gil S, Germond A, Fountain C, Baldessari A, Roffler S, Kiem HP, Fuller DH, Lieber A. In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor. Hum Gene Ther. 2022 Apr;33(7-8):389-403. doi: 10.1089/hum.2021.295. PubMed PMID: 35057635; PubMed Central PMCID: PMC9063208.
  11. O’Connor MA, Erasmus JH, Randall S, Archer J, Lewis TB, Brown B, Fredericks M, Groenier S, Iwayama N, Ahrens C, Garrison W, Wangari S, Guerriero KA, Fuller DH. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques. Front Immunol. 2021;12:800723. doi: 10.3389/fimmu.2021.800723. eCollection 2021. PubMed PMID: 34992610; PubMed Central PMCID: PMC8724308.
  12. Hawman DW, Meade-White K, Archer J, Leventhal S, Wilson D, Shaia C, Randall S, Khandhar AP, Hsiang TY, Gale M Jr, Berglund P, Fuller DH, Feldmann H, Erasmus JH. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern. bioRxiv. 2021 Dec 13;. doi: 10.1101/2021.12.10.472134. PubMed PMID: 34931189; PubMed Central PMCID: PMC8687464.
  13. Willcox AC, Sung K, Garrett ME, Galloway JG, Oâ Connor MA, Erasmus JH, Logue JK, Hawman DW, Chu HY, Hasenkrug KJ, Fuller DH, Matsen FA, Overbaugh J. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection. bioRxiv. 2021 Dec 3;. doi: 10.1101/2021.12.01.470697. PubMed PMID: 34909774; PubMed Central PMCID: PMC8669841.
  14. VanBenschoten HM, Woodrow KA. Vaginal delivery of vaccines. Adv Drug Deliv Rev. 2021 Nov;178:113956. doi: 10.1016/j.addr.2021.113956. Epub 2021 Sep 1. Review. PubMed PMID: 34481031; PubMed Central PMCID: PMC8722700.
  15. Kuley R, Draves KE, Fuller DH, Giltiay NV, Clark EA, Giordano D. B cell activating factor (BAFF) from neutrophils and dendritic cells is required for protective B cell responses against Salmonella typhimurium infection. PLoS One. 2021;16(10):e0259158. doi: 10.1371/journal.pone.0259158. eCollection 2021. PubMed PMID: 34705890; PubMed Central PMCID: PMC8550399.
  16. Walls AC, Miranda MC, Schäfer A, Pham MN, Greaney A, Arunachalam PS, Navarro MJ, Tortorici MA, Rogers K, O’Connor MA, Shirreff L, Ferrell DE, Bowen J, Brunette N, Kepl E, Zepeda SK, Starr T, Hsieh CL, Fiala B, Wrenn S, Pettie D, Sydeman C, Sprouse KR, Johnson M, Blackstone A, Ravichandran R, Ogohara C, Carter L, Tilles SW, Rappuoli R, Leist SR, Martinez DR, Clark M, Tisch R, O’Hagan DT, Van Der Most R, Van Voorhis WC, Corti D, McLellan JS, Kleanthous H, Sheahan TP, Smith KD, Fuller DH, Villinger F, Bloom J, Pulendran B, Baric RS, King NP, Veesler D. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. Cell. 2021 Oct 14;184(21):5432-5447.e16. doi: 10.1016/j.cell.2021.09.015. Epub 2021 Sep 15. PubMed PMID: 34619077; PubMed Central PMCID: PMC8440233.
  17. O’Connor MA, Munson PV, Dross SE, Tunggal HC, Lewis TB, Osborn J, Peterson CW, Huang MW, Moats C, Smedley J, Jerome KR, Kiem HP, Bagley KC, Mullins JI, Fuller DH. A Gut Reaction to SIV and SHIV Infection: Lower Dysregulation of Mucosal T Cells during Acute Infection Is Associated with Greater Viral Suppression during cART. Viruses. 2021 Aug 14;13(8). doi: 10.3390/v13081609. PubMed PMID: 34452474; PubMed Central PMCID: PMC8402906.
  18. Guerriero KA, Murnane RD, Lewis TB, Brown B, Baldessari A, Jeffery DA, Malinowski CM, Fuller DH, O’Connor MA. Recrudescence of Natural Coccidioidomycosis During Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus. AIDS Res Hum Retroviruses. 2021 Jul;37(7):505-509. doi: 10.1089/AID.2020.0228. Epub 2021 Feb 23. PubMed PMID: 33356854; PubMed Central PMCID: PMC8260887.
  19. Tunggal HC, Munson PV, O’Connor MA, Hajari N, Dross SE, Bratt D, Fuller JT, Bagley K, Fuller DH. Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs. PLoS One. 2021;16(6):e0253265. doi: 10.1371/journal.pone.0253265. eCollection 2021. PubMed PMID: 34138927; PubMed Central PMCID: PMC8211199.
  20. Wood MP, Jones CI, Lippy A, Oliver BG, Walund B, Fancher KA, Fisher BS, Wright PJ, Fuller JT, Murapa P, Habib J, Mavigner M, Chahroudi A, Sather DN, Fuller DH, Sodora DL. Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques. PLoS Pathog. 2021 May;17(5):e1009575. doi: 10.1371/journal.ppat.1009575. eCollection 2021 May. PubMed PMID: 33961680; PubMed Central PMCID: PMC8133453.
  21. Klatt NR, Broedlow C, Osborn JM, Gustin AT, Dross S, O’Connor MA, Coronado E, Barnette P, Hensley-McBain T, Zevin AS, Muir R, Roederer A, Wangari S, Iwayama N, Ahrens CY, Smedley J, Moats C, Lynch RM, Haddad EK, Haigwood NL, Fuller DH, Manuzak JA. Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques. NPJ Vaccines. 2021 Mar 11;6(1):34. doi: 10.1038/s41541-021-00298-4. PubMed PMID: 33707443; PubMed Central PMCID: PMC7952719.
  22. Malherbe DC, Vang L, Mendy J, Barnette PT, Spencer DA, Reed J, Kareko BW, Sather DN, Pandey S, Wibmer CK, Robins H, Fuller DH, Park B, Lakhashe SK, Wilson JM, Axthelm MK, Ruprecht RM, Moore PL, Sacha JB, Hessell AJ, Alexander J, Haigwood NL. Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge. Front Immunol. 2020;11:626464. doi: 10.3389/fimmu.2020.626464. eCollection 2020. PubMed PMID: 33658998; PubMed Central PMCID: PMC7917243.
  23. Linsky TW, Vergara R, Codina N, Nelson JW, Walker MJ, Su W, Barnes CO, Hsiang TY, Esser-Nobis K, Yu K, Reneer ZB, Hou YJ, Priya T, Mitsumoto M, Pong A, Lau UY, Mason ML, Chen J, Chen A, Berrocal T, Peng H, Clairmont NS, Castellanos J, Lin YR, Josephson-Day A, Baric RS, Fuller DH, Walkey CD, Ross TM, Swanson R, Bjorkman PJ, Gale M Jr, Blancas-Mejia LM, Yen HL, Silva DA. De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2.Science. 2020 Dec 4;370(6521):1208-1214. doi: 10.1126/science.abe0075. Epub 2020 Nov 5. PubMed PMID: 33154107; PubMed Central PMCID: PMC7920261.
  24. Walls AC, Miranda MC, Pham MN, Schäfer A, Greaney A, Arunachalam PS, Navarro MJ, Tortorici MA, Rogers K, O’Connor MA, Shireff L, Ferrell DE, Brunette N, Kepl E, Bowen J, Zepeda SK, Starr T, Hsieh CL, Fiala B, Wrenn S, Pettie D, Sydeman C, Johnson M, Blackstone A, Ravichandran R, Ogohara C, Carter L, Tilles SW, Rappuoli R, O’Hagan DT, Van Der Most R, Van Voorhis WC, McLellan JS, Kleanthous H, Sheahan TP, Fuller DH, Villinger F, Bloom J, Pulendran B, Baric R, King N, Veesler D. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. bioRxiv. 2021 Mar 16;. doi: 10.1101/2021.03.15.435528. PubMed PMID: 33758839; PubMed Central PMCID: PMC7986998.
  25. Powell RL, Weiss S, Fox A, Liu X, Itri V, Jiang X, Luo CC, Spencer DA, Pandey S, Cheever T, Fuller DH, Totrov M, Hessell AJ, Haigwood NL, Kong XP, Zolla-Pazner S. An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques. J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01175-20. Print 2020 Aug 17. PubMed PMID: 32554699; PubMed Central PMCID: PMC7431793.
  26. Erasmus JH, Khandhar AP, O’Connor MA, Walls AC, Hemann EA, Murapa P, Archer J, Leventhal S, Fuller JT, Lewis TB, Draves KE, Randall S, Guerriero KA, Duthie MS, Carter D, Reed SG, Hawman DW, Feldmann H, Gale M Jr, Veesler D, Berglund P, Fuller DH. An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci Transl Med. 2020 Aug 5;12(555). doi: 10.1126/scitranslmed.abc9396. Epub 2020 Jul 20. PubMed PMID: 32690628; PubMed Central PMCID: PMC7402629
  27. Malherbe DC, Wibmer CK, Nonyane M, Reed J, Sather DN, Spencer DA, Schuman JT, Guo B, Pandey S, Robins H, Park B, Fuller DH, Sacha JB, Moore PL, Hessell AJ, Haigwood NL. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development. Front Immunol. 2020;11:984. doi: 10.3389/fimmu.2020.00984. eCollection 2020. PubMed PMID: 32582155; PubMed Central PMCID: PMC7280454.
  28. Erasmus, JH, Fuller DH (2020). Preparing for pandemics: RNA vaccines at the forefront. Mol Ther. Jul 8;28(7):1559-1560. doi: 10.1016/j.ymthe.2020.06.017. PMID: 32579882.
  29. Fuller DH, Berglund P. Amplifying RNA Vaccine Development. N Engl J Med. 2020 Jun 18;382(25):2469-2471. doi: 10.1056/NEJMcibr2009737. PubMed PMID: 32558474., Berglund P. Amplifying RNA Vaccine Development. N Engl J Med. 2020 Jun 18;382(25):2469-2471. doi: 10.1056/NEJMcibr2009737. PubMed PMID: 32558474.
  30. Gorini G, Fourati S, Vaccari M, Rahman MA, Gordon SN, Brown DR, Law L, Chang J, Green R, Barrenäs F, Liyanage NPM, Doster MN, Schifanella L, Bissa M, Silva de Castro I, Washington-Parks R, Galli V, Fuller DH, Santra S, Agy M, Pal R, Palermo RE, Tomaras GD, Shen X, LaBranche CC, Montefiori DC, Venzon DJ, Trinh HV, Rao M, Gale M Jr, Sekaly RP, Franchini G. Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition. PLoS Pathog. 2020 Mar;16(3):e1008377. doi: 10.1371/journal.ppat.1008377. eCollection 2020 Mar. PubMed PMID: 32163525; PubMed Central PMCID: PMC7093029.
  31. Wood MP, Wood L, Templeton M, Fisher B, Lippy A, Joes CI, Arlehamn L, Fuller J, Murapa P, Jaspan H, Fuller DH, Sodora D (2020). Transient immune activiation associated with BCG vaccination of infant rhesus macaques is not sufficient to influence oral simian immunodeficiency virus infection. JID org/10.1093/infdis/jiz382; PMID: 31605528.
  32. Hessell AJ, Powell R, Jiang X, Luo C, Weiss S, Dussupt V, Itri V, Fox A, Shapiro MB, Pandey S, Cheever T, Fuller DH, Park B, Krebs SJ, Totrov M, Haigwood NL (2019). Multimeric epitope-scaffold HIV vaccine target V1V2 and differentially tune polyfunctional antibody responses. Cell Reports 28 (4): 877-895 PMID 31340151
  33. Bar KJ, Coronado E, Hensley-McBain T, O’Connor MA, Osborn JM, Miller C, Gott TM, Wangari S, Iwayama N, Ahrens CY, Smedley J, Moats C, Lynch RM, Haddad EK, Haigwood NL, Fuller DH, Shaw GM, Klatt NR, Manuzak JA. Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology. J Virol. 2019 Sep 15;93(18). doi: 10.1128/JVI.00372-19. Print 2019 Sep 15. PubMed PMID: 31217249; PubMed Central PMCID: PMC6714786.
  34. O’Connor MA, Munson PV, Tunggal HC, Hajari N, Lewis TB, Bratt D, Moats C, Smedley J, Bagley KC, Mullins JI, Fuller DH (2019). Mucosal T helper 17 and T regulatory cell homeostasis correlates with acute SIV viremia and responsiveness to antiretroviral therapy in macaques. AIDS Research and Human Retroviruses; org/10.1089/aid.2018.0184, PMID: 30398361
  35. O’Connor MA, Tisoncik-Go J, Lewis TB, Miller CJ, Bratt D, Moats CR, Edlefsen PT, Smedley J, Klatt NR, Gale M Jr, Fuller DH. Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaques. Nat Commun. 2018 Aug 22;9(1):3371. doi: 10.1038/s41467-018-05826-w. PubMed PMID: 30135445; PubMed Central PMCID: PMC6105614.
  36. Ramsingh AI, Gray SJ, Reilly A, Koday M, Bratt D, Koday MT, Munson PM, Murnane R, Smedley J, Hu Y, Messer A, Fuller DH. Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation. PLoS One. 2018;13(6):e0198154. doi: 10.1371/journal.pone.0198154. eCollection 2018. PubMed PMID: 29874260; PubMed Central PMCID: PMC5991358.
  37. Munson PV, Tunggal H, O’Connor M, Bratt D, May A, Wangari S, Agricola B, Smedley J, Fuller JT, Kulkarni V, Felber, BK, Pavlakis GN, Mullins JI, Fuller DH (2018). Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during chronic viral infection. Human Vaccines and Immunotherapy DOI: 1080/21645515.2018.1448328; PMID: 29648490
  38. Koday MT, Leonard J, Fuller JT, Bratt D, Koday M, Fuller DH (2017). Multivalent Influenza DNA Vaccine Induces Potent Antibodies and Broadly-Specific T Cell Responses in Non-human Primates, PLoS One https://doi.org/10.1371/journal.pone.0189780. PMID: 29267331
  39. Chevalier A, Silva D-A, Rocklin G-J, Hicks DR, Vergara R, Murapa P, Bernard SM, Zhang L, Lam K-H,Yao G, Bahl CD, Miyashita S-I, Inna G, Fuller JT, Koday MT, Jenkins C, Colvin T, Carter L, Bohn A, Bryan CM, Fernandez-Velasco DA, Stewart L, Dong M, Huang X, Jin R, Wilson IA, Fuller DH, Baker D (2017). Massively parallel de novo protein design for targeted therapeutics, Nature 550 (7674): 74-79; DOI: doi:10.1038/nature23912, PMID: 28953867.
  40. Strauch EM, Bernard SM, Bohn AJ, Lee PS, Anderson, CE, Nieusma T, Holstein CA, La D, Garcia NK, Hooper KA, Ravichandran R, Nelson J, Sheffler W, Bloom JD, Lee KK, Ward AB, Yager P, Fuller DH, Wilson IA, Baker D (2017). Design of trimeric influenza neutralizing proteins targeting the hemagglutinin receptor binding site. Nature Biotechnology 35(7): 667-71. DOI:1038/nbt.3907. PMID: 28604661.
  41. Dross SE, Munson P, Kim, SE, Bratt, D, Gervassi, A, Fuller DH, Horton, H (2016). Kinetics of myeloid derived suppressor cell frequency and function during SIV infection and combination antiretroviral therapy. J Immunol. 198(2): 757-766; DOI: 4049/jimmunol.1600759; PMID: 27974456.
  42. Smedley J, Macalister R, Wangari S, Gathuka M, Ahrens J, Iwayama N, May D, Bratt D, O’Connor M, Munson P, Koday M, Lifson, Fuller DH. Correction: Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques. PLoS One.2018;13(1):e0190764. doi: 10.1371/journal.pone.0190764. eCollection 2018. PubMed PMID: 29293690; PubMed Central PMCID: PMC5749853.
  43. McBurney SP, Sunshing JE, Huynh GS, Sutton WF, Fuller DH, Haigwood NL, Messer WB (2016). Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates. Vaccine 24;34(30):3500-7. doi: 10.1016/j.vaccine.2016.03.108. PMID: 27085173.
  44. Stone BC, Kas A, Billman ZP, Fuller DH, Fuller JT, Shendure J, Murphy SC. (2016). Complex minigene library vaccination for discovery of pre-erythrocytic Plasmodium T cell antigens PLoS One 11(4): e0153449. doi:10.1371/journal.pone.0153449, PMID: 27070430, PCMID:PMC 4829254.
  45. Hessell A, Malherbe D, Pissani F, McBurney S, Krebs S, Gomes M, Pandey S, Sutton W, Burwitz B, Gray M, Robins H, Park B, Sacha J, LaBranche C, Fuller DH, Montefiori D, Stamatatos L, Sather N, Haigwood N. (2016). Achieving potent autologous neutralizing antibody responses against Tier 2 viruses by strategic selection of Env immunogen, Journal of Immunology 196(7):3064-78. doi: 10.4049/jimmunol.1500527, PMID: 26944928, PCMID:PMC 4797725.
  46. Rosinski SL, Stone, BC, Graves S, Fuller DH, Fuller JT, Storb R (2016). Donor Conversion Following Minor Antigen Vaccine-Sensitized DLI Does Not Correlate with the Level of Donor Sensitization. Transplantation Direct 8;2(5):e71. doi: 10.1097/TXD.0000000000000583. PMID:27430015.
  47. Koday MT, Nelson J, Chevalier A, Koday M, Kalinoski H, Stewart L, Carter L, Nieusma T, Lee PS, Ward AB, Wilson IA, Dagley A, Smee DF, Baker D, Fuller DH (2016). A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response.PLoS Pathog: doi: 10.1371/journal.ppat.1005409. PubMed PMID: 26845438; PMCID: PMC4742065